|
Event
|
Metoclopramide group
|
Domperidone group
|
Control group
|
P
value
|
|---|
|
(
n
= 100)
|
(
n
= 99)
|
(
n
= 99)
|
|---|
|
Any event
|
20 (20.0)
|
10 (10.1)
|
13 (13.1)
|
0.126
|
|
Drug-associated events
| | | | |
|
Lethargy
|
2 (2.0)
|
0
|
0
|
0.136
|
|
Dysphoria
|
1 (1.0)
|
0
|
0
|
0.370
|
|
Amyostasia
|
1 (1.0)
|
0
|
0
|
0.370
|
|
Pruritus
|
0
|
1 (1.0)
|
0
|
0.365
|
|
Tube-associated events
| | | | |
|
Nasal mucosa bleeding
|
8 (8.0)
|
5 (5.1)
|
8 (8.1)
|
0.637
|
|
Airway misplacement
|
1 (1.0)
|
0
|
1 (1.0)
|
0.606
|
|
Pain
|
2 (2.0)
|
3 (3.0)
|
2 (2.0)
|
0.861
|
|
Nausea
|
4 (4.0)
|
1 (1.0)
|
1 (1.0)
|
0.222
|
|
Vomiting
|
1 (1.0)
|
1 (1.0)
|
1 (1.0)
|
1.000
|
